Regulating amyloid precursor protein synthesis through an internal ribosomal entry site

Expression of amyloid precursor protein (APP) is critical to the etiology of Alzheimer's disease (AD). Consequently, regulating APP expression is one approach to block disease progression. To this end, APP can be targeted at the levels of transcription, translation, and protein stability. Little is currently known about the translation of APP mRNA. Here, we report that endogenous APP mRNA is translated in neural cell lines via an internal ribosome entry site (IRES) located in the 5′-untranslated leader. The functional unit of the APP IRES is located within the 5′ 50 nucleotides of the 5′-leader. In addition, we found that the APP IRES is positively regulated by two conditions correlated with AD, increased intracellular iron concentration and ischemia. Interestingly, the enhancement of APP IRES activity is dependent upon de novo transcription. Taken together, our data suggest that internal initiation of translation of the APP mRNA is an important mode for synthesis of APP, a mechanism which is regulated by conditions that also contribute to AD.

[1]  D. Lahiri.  Functional Characterization of Amyloid β Precursor Protein Regulatory Elements: Rationale for the Identification of Genetic Polymorphism , 2004, Annals of the New York Academy of Sciences.

[2]  P. Hof,et al.  Brain Microvascular Changes in Alzheimer's Disease and Other Dementias a , 1997, Annals of the New York Academy of Sciences.

[3]  S. Cornelis,et al.  UNR translation can be driven by an IRES element that is negatively regulated by polypyrimidine tract binding protein , 2005, Nucleic acids research.

[4]  D. Selkoe,et al.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.

[5]  G. Perry,et al.  Oxidative Stress and Redox‐Active Iron in Alzheimer's Disease , 2004, Annals of the New York Academy of Sciences.

[6]  B. Pappas,et al.  Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion , 2000, Neurobiology of Aging.

[7]  J. Connor,et al.  A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains , 1995, Journal of neurochemistry.

[8]  W. Merrick.  Cap-dependent and cap-independent translation in eukaryotic systems. , 2004, Gene.

[9]  B. Semler,et al.  IRES-mediated pathways to polysomes: nuclear versus cytoplasmic routes. , 2008, Trends in microbiology.

[10]  Yi Wen Kong,et al.  Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. , 2006, Molecular cell.

[11]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[12]  A. Akaike,et al.  Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro. , 2002, European journal of pharmacology.

[13]  A. Prats,et al.  Translational Induction of VEGF Internal Ribosome Entry Site Elements During the Early Response to Ischemic Stress , 2007, Circulation research.

[14]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[15]  Jill T. Jamison,et al.  Persistent redistribution of poly-adenylated mRNAs correlates with translation arrest and cell death following global brain ischemia and reperfusion , 2008, Neuroscience.

[16]  M. Kozak.  Alternative ways to think about mRNA sequences and proteins that appear to promote internal initiation of translation. , 2003, Gene.

[17]  J. L. Quesne,et al.  C-Myc 5′ untranslated region contains an internal ribosome entry segment , 1998, Oncogene.

[18]  G M Edelman,et al.  Internal initiation of translation of five dendritically localized neuronal mRNAs , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Greengard,et al.  Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Xudong Huang,et al.  Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.

[21]  L. Krushel,et al.  Internal initiation of translation of the TrkB mRNA is mediated by multiple regions within the 5′ leader , 2005, Nucleic acids research.

[22]  A. Prochiantz,et al.  Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro , 1995, The Journal of cell biology.

[23]  Jinfang Li,et al.  The dicistronic RNA from the mouse LINE-1 retrotransposon contains an internal ribosome entry site upstream of each ORF: implications for retrotransposition , 2006, Nucleic acids research.

[24]  V. Belegu,et al.  Specific repression of β-globin promoter activity by nuclear ferritin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[26]  Wei Xu,et al.  Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita , 2006, Science.

[27]  J. Hardy,et al.  Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease , 2005, Neurobiology of Aging.

[28]  M. Bushell,et al.  Re‐programming of translation following cell stress allows IRES‐mediated translation to predominate , 2008, Biology of the cell.

[29]  J. C. Torre,et al.  Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease , 2008, Neurodegenerative Diseases.

[30]  M. Hentze,et al.  Molecular mechanisms of translational control , 2004, Nature Reviews Molecular Cell Biology.

[31]  M. V. van Eden,et al.  Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures. , 2004, RNA.

[32]  Rita Kumar,et al.  Molecular Pathways of Protein Synthesis Inhibition during Brain Reperfusion: Implications for Neuronal Survival or Death , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[34]  Stéphan Vagner,et al.  Irresistible IRES , 2001, EMBO reports.

[35]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[36]  Elizabeth C. Theil,et al.  Internal loop/bulge and hairpin loop of the iron-responsive element of ferritin mRNA contribute to maximal iron regulatory protein 2 binding and translational regulation in the iso-iron-responsive element/iso-iron regulatory protein family. , 2000, Biochemistry.

[37]  K. Pantopoulos.  Iron Metabolism and the IRE/IRP Regulatory System: An Update , 2004, Annals of the New York Academy of Sciences.

[38]  J. Ryder,et al.  Inhibition of Aβ production and APP maturation by a specific PKA inhibitor , 2003 .

[39]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[40]  S. Snyder,et al.  Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation in Ischemic Stroke Linked to Neural Damage , 1999, The Journal of Neuroscience.

[41]  L. Kenner,et al.  The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. , 2007, Blood.

[42]  J. Connor,et al.  Interactions and Reactions of Ferritin with DNA* , 2004, Journal of Biological Chemistry.

[43]  P. Sarnow,et al.  Internal ribosome entry sites in eukaryotic mRNA molecules. , 2001, Genes & development.

[44]  K. Pantopoulos,et al.  Conditional Derepression of Ferritin Synthesis in Cells Expressing a Constitutive IRP1 Mutant , 2002, Molecular and Cellular Biology.

[45]  N. Sonenberg,et al.  Poliovirus translation: A paradigm for a novel initiation mechanism , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.

[46]  N. Sonenberg,et al.  Regulation of cap-dependent translation by eIF4E inhibitory proteins , 2005, Nature.

[47]  D. Richardson.  Novel Chelators for Central Nervous System Disorders That Involve Alterations in the Metabolism of Iron and Other Metal Ions , 2004, Annals of the New York Academy of Sciences.

[48]  Kinzo Matsumoto,et al.  Expression changes of the mRNA of Alzheimer's disease related factors in the permanent ischemic rat brain. , 2004, Biological & pharmaceutical bulletin.

[49]  N. Gray,et al.  Control of translation initiation in animals. , 1998, Annual review of cell and developmental biology.

[50]  C. Masters.  ETIOLOGY AND PATHOGENESIS OF ALZHEIMER'S DISEASE , 1984, Pathology.

[51]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[52]  H. Wiśniewski,et al.  Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain , 1994, Brain Research.

[53]  R. E. Lockard,et al.  Requirement for 7-methylguanosine in translation of globin mRNA in vivo. , 1978, Nucleic Acids Research.

[54]  C. Levenson,et al.  Iron and ageing: an introduction to iron regulatory mechanisms , 2004, Ageing Research Reviews.

[55]  G. Caporaso.  Chloroquine inhibits intracellular segradation but not decretion of Alzheimerβ/A4 amyloid precursor protein. , 1992 .

[56]  P. Brown,et al.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[58]  P. Sarnow,et al.  Preferential Translation of Internal Ribosome Entry Site-containing mRNAs during the Mitotic Cycle in Mammalian Cells* , 2004, Journal of Biological Chemistry.

[59]  A. Komar,et al.  Internal Ribosome Entry Sites in Cellular mRNAs: Mystery of Their Existence* , 2005, Journal of Biological Chemistry.

[60]  Xudong Huang,et al.  An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript* , 2002, The Journal of Biological Chemistry.

[61]  Bryan Maloney,et al.  Characterization of the APP proximal promoter and 5′‐untranslated regions: identification of cell‐type specific domains and implications in APP gene expression and Alzheimer's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  A. Goate,et al.  Presenilin function and γ‐secretase activity , 2005, Journal of neurochemistry.

[63]  P. Hyslop,et al.  Inhibition of abeta production and APP maturation by specific PKA inhibitors , 2000, Neurobiology of Aging.

[64]  D. Lahiri,et al.  Role of the APP Promoter in Alzheimer's Disease: Cell Type‐Specific Expression of the β‐Amyloid Precursor Protein , 2004, Annals of the New York Academy of Sciences.

[65]  D. Ganem,et al.  Mechanisms Governing Expression of the v-FLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[66]  I. Batinic-Haberle,et al.  Oxidants, antioxidants and the ischemic brain , 2004, Journal of Experimental Biology.

[67]  R. Kalaria.  The role of cerebral ischemia in Alzheimer’s disease , 2000, Neurobiology of Aging.

[68]  T. Korten,et al.  Iron accumulation, iron‐mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate , 2004, Journal of neurochemistry.